EnteroMedics

homesitemapcontact us

   search

 

   
 
 
   
   
 

Overview

 

About vBloc® Therapy

 
 

vBloc® Maestro® System

 
 

Obesity

 
 

Clinical Experience

 
 

     Obesity

 
 

     Diabetes

 
 

     Cardiovascular Disease

 
 

Publications

 

.
Important Safety Information for Patients >
 

 

 

The Maestro® Rechargeable System has received CE Mark for the treatment of obesity and Type 2 diabetes mellitus through improved glycemic control, and has been listed on the Australian Register of Therapeutic Goods (ARTG) by the Therapeutic Goods Administration (TGA) for supply in Australia.